Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Jackson

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
Evidence for abundant isolated magnetic nanoparticles at the Paleocene-Eocene boundaryHuapei Wang, Dennis V Kent, Michael J Jackson
Brain Research|September 12, 2006
Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's diseaseJoanna Iczkiewicz, Michael J Jackson, Lance A Smith, et al.
Journal of Public Health (Oxford, England)|March 10, 2025
Post-polio hospital admissions in Australia over a 10-year period: An observational study and analysis of trends by month, location, and comparable conditionsTimothy J H Lathlean, Nigel Quadros, Akhilesh K Ramachandran, et al.
Behavioural Pharmacology|April 28, 2011
A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosetsMatthew J Hansard, Michael J Jackson, Lance A Smith, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 10, 2003
3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primatesMahmoud M Iravani, Michael J Jackson, Mikko Kuoppamäki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2003
Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposureLance A Smith, Michael J Jackson, Matthew J Hansard, et al.
Journal of Molecular Neuroscience : MN|October 24, 2013
Proteomic analysis of striatum from MPTP-treated marmosets (Callithrix jacchus) with L-DOPA-induced dyskinesia of differing severityMichael J Hurley, Michael J Jackson, Lance A Smith, et al.
Experimental Neurology|November 23, 2006
Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosetsMichael J Jackson, Lance A Smith, Ghassan Al-Barghouthy, et al.
Journal of Rehabilitation Medicine|April 20, 2021
Effects of muscle strengthening and cardiovascular fitness activities for poliomyelitis survivors: A systematic review and meta-analysisAkhilesh Kumar Ramachandran, Stephen P J Goodman, Michael J Jackson, et al.
European Journal of Pharmacology|September 17, 2002
Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primatesMatthew J Hansard, Lance A Smith, Michael J Jackson, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
Evidence for abundant isolated magnetic nanoparticles at the Paleocene-Eocene boundaryHuapei Wang, Dennis V Kent, Michael J Jackson
Brain Research|September 12, 2006
Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's diseaseJoanna Iczkiewicz, Michael J Jackson, Lance A Smith, et al.
Journal of Public Health (Oxford, England)|March 10, 2025
Post-polio hospital admissions in Australia over a 10-year period: An observational study and analysis of trends by month, location, and comparable conditionsTimothy J H Lathlean, Nigel Quadros, Akhilesh K Ramachandran, et al.
Behavioural Pharmacology|April 28, 2011
A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosetsMatthew J Hansard, Michael J Jackson, Lance A Smith, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 10, 2003
3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primatesMahmoud M Iravani, Michael J Jackson, Mikko Kuoppamäki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2003
Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposureLance A Smith, Michael J Jackson, Matthew J Hansard, et al.
Journal of Molecular Neuroscience : MN|October 24, 2013
Proteomic analysis of striatum from MPTP-treated marmosets (Callithrix jacchus) with L-DOPA-induced dyskinesia of differing severityMichael J Hurley, Michael J Jackson, Lance A Smith, et al.
Experimental Neurology|November 23, 2006
Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosetsMichael J Jackson, Lance A Smith, Ghassan Al-Barghouthy, et al.
Journal of Rehabilitation Medicine|April 20, 2021
Effects of muscle strengthening and cardiovascular fitness activities for poliomyelitis survivors: A systematic review and meta-analysisAkhilesh Kumar Ramachandran, Stephen P J Goodman, Michael J Jackson, et al.
European Journal of Pharmacology|September 17, 2002
Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primatesMatthew J Hansard, Lance A Smith, Michael J Jackson, et al.
Pageof 4